Neil is a patent litigator who has established a reputation in the pharma and medical device fields.
Neil is a partner in the intellectual property group based in London. Although his practice is focused on patent litigation, it also encompasses trade secrets, designs and trade marks as well as such associated matters as regulatory data exclusivity, supplementary protection certificates, labelling and advertising.
His cases that have come to trial before the English Courts and in the CFI over the years include PLG v Ardon (plastic grids), ICI v Montedison (polymer composite), HCC v BP (acetic acid purification), UCC v BP (fluid bed production of polyethylene), Stephenson v Du Pont (entitlement), Hesco v Maccaferri (gabions), Chef Revival v OHIM (Chef mark), Agilent v Waters (HPLC pumps), Teva v Merck (alendronate), Teva v Merck (simvastatin), Lundbeck v Niche (citalopram), Abbott v APS (clarithromycin), Celltech v OHIM (Celltech mark), Actavis v Merck (finasteride), Actavis v Novartis (fluvastatin), Specialty Brands v OHIM (Dog Device), Teva v Merck (timolol/dorzolamide combination), Generics v Yeda/Teva (Copaxone), Novartis v Teva (rivastigmine) and Synthon v Teva (Copaxone).
Neil speaks regularly at IP conferences and contributes to the leading IP journals on many aspects of IP law and litigation as well as being the editor of International Intellectual Property Litigation (published by Thomson Reuters).
He joined Bird & Bird in 1986 and became a partner in 1996.
Chambers UK (2016) says: "Neil Jenkins is one of the firm's most esteemed patent litigators and has a prestigious client following in the field. Sources say he is ‘a terrific lawyer and litigator’ and ‘extremely clever in his strategy’.”
Chambers UK (2015) says: “Neil Jenkins has a comprehensive IP litigation practice which covers all rights, although his metier is in leading cross-border patent disputes. One market source says: ‘He's very experienced and very thorough - really knows his stuff.’”
IAM Patent 1000 (2015) describes him as a "pharmaceutical ace", adding: “He has deep knowledge of patent law and litigation tactics, coupled with industry insight, which ensures that his advice is not just technically correct, but commercially relevant.”
WWL says: “One of the leading lights in his field”
This biography is an extract from Who's Who Legal: Life Sciences which can be purchased from our Shop.